Terms: = Uterine cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Prognosis
4 results:
1. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
2. Expression of immune cell markers and tumor markers in patients with cervical cancer.
Zhang L; Zhang H; Huang Y; Xi X; Sun Y
Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
[TBL] [Abstract] [Full Text] [Related]
3. Central nervous system involvement in gestational trophoblastic neoplasia.
Ayhan A; Tuncer ZS; Tanir M; Erbengi A
Acta Obstet Gynecol Scand; 1996 Jul; 75(6):548-50. PubMed ID: 8693931
[TBL] [Abstract] [Full Text] [Related]
4. cancer of the uterine cervix in Norway by histologic type, 1970-84.
Eide TJ
J Natl Cancer Inst; 1987 Aug; 79(2):199-205. PubMed ID: 3474452
[TBL] [Abstract] [Full Text] [Related]
